Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels

Am J Physiol Cell Physiol. 2006 Oct;291(4):C726-39. doi: 10.1152/ajpcell.00003.2006. Epub 2006 May 17.

Abstract

We previously demonstrated the expression of bitter taste receptors of the type 2 family (T2R) and the alpha-subunits of the G protein gustducin (Galpha(gust)) in the rodent gastrointestinal (GI) tract and in GI endocrine cells. In this study, we characterized mechanisms of Ca(2+) fluxes induced by two distinct T2R ligands: denatonium benzoate (DB) and phenylthiocarbamide (PTC), in mouse enteroendocrine cell line STC-1. Both DB and PTC induced a marked increase in intracellular [Ca(2+)] ([Ca(2+)](i)) in a dose- and time-dependent manner. Chelating extracellular Ca(2+) with EGTA blocked the increase in [Ca(2+)](i) induced by either DB or PTC but, in contrast, did not prevent the effect induced by bombesin. Thapsigargin blocked the transient increase in [Ca(2+)](i) induced by bombesin, but did not attenuate the [Ca(2+)](i) increase elicited by DB or PTC. These results indicate that Ca(2+) influx mediates the increase in [Ca(2+)](i) induced by DB and PTC in STC-1 cells. Preincubation with the L-type voltage-sensitive Ca(2+) channel (L-type VSCC) blockers nitrendipine or diltiazem for 30 min inhibited the increase in [Ca(2+)](i) elicited by DB or PTC. Furthermore, exposure to the L-type VSCCs opener BAY K 8644 potentiated the increase in [Ca(2+)](i) induced by DB and PTC. Stimulation with DB also induced a marked increase in the release of cholecystokinin from STC-1 cells, an effect also abrogated by prior exposure to EGTA or L-type VSCC blockers. Collectively, our results demonstrate that bitter tastants increase [Ca(2+)](i) and cholecystokinin release through Ca(2+) influx mediated by the opening of L-type VSCCs in enteroendocrine STC-1 cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / physiology*
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Cell Line
  • Cholecystokinin / metabolism*
  • Enteroendocrine Cells / drug effects
  • Enteroendocrine Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / metabolism
  • Mice
  • Mice, Transgenic
  • Phenylthiourea / pharmacology
  • Proteins / metabolism
  • Pyrrolidinones / pharmacology
  • Quaternary Ammonium Compounds / pharmacology
  • Signal Transduction / physiology
  • Sodium / metabolism
  • TRPM Cation Channels / metabolism
  • Taste / physiology*
  • Time Factors
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Enzyme Inhibitors
  • Estrenes
  • Proteins
  • Pyrrolidinones
  • Quaternary Ammonium Compounds
  • TRPM Cation Channels
  • TRPM4 protein, mouse
  • Trpm5 protein, mouse
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • denatonium benzoate
  • Phenylthiourea
  • Cholecystokinin
  • Sodium
  • Type C Phospholipases
  • Calcium